GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011490 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Isela Sarahi Rivera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Chromatin, Genetic Predisposition to Disease, Prostatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council Queensland, QIMR Berghofer Maureen Stevenson PhD Scholarship, Queensland University of Technology.
Abstract (Originalsprache)
Hormone-dependent cancers (HDCs) share several risk factors, suggesting a common aetiology. Using data from genome-wide association studies, we showed spatial clustering of risk variants across four HDCs (breast, endometrial, ovarian and prostate cancers), contrasting with genetically uncorrelated traits. We identified 44 multi-HDC risk regions across the genome, defined as overlapping risk regions for at least two HDCs: two regions contained risk variants for all four HDCs, 13 for three HDCs and 28 for two HDCs. Integrating GWAS data, epigenomic profiling and promoter capture HiC maps from diverse cell line models, we annotated 53 candidate risk genes at 22 multi-HDC risk regions. These targets were enriched for established genes from the COSMIC Cancer Gene Census, but many had no previously reported pleiotropic roles. Additionally, we pinpointed lncRNAs as potential HDC targets and identified risk alleles in several regions that altered transcription factors motifs, suggesting regulatory mechanisms. Known drug targets were over-represented among the candidate multi-HDC risk genes, implying that some may serve as targets for therapeutic development or facilitate the repurposing of existing treatments for HDC. Our approach provides a framework for identifying common target genes driving complex traits and enhances understanding of HDC susceptibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
- Faculty of Health, Queensland University of Technology, Brisbane, Australia.
- Faculty of Medicine, The University of Queensland, Brisbane, Australia.
- Department of Infectious Disease, Imperial College London, London, United Kingdom.
ORCID-Profile: Juliet D French, Haran Sivakumaran, Kristine M Hillman, Mahdi Moradi Marjaneh, Stacey L Edwards
Förderung
- Cancer Council Queensland
- QIMR Berghofer Maureen Stevenson PhD Scholarship
- Queensland University of Technology
- Isabel and Roderic Allpass
- National Health and Medical Research Council
Zitieren
APA
Rivera, I. S., French, J. D., Bitar, M., Sivakumaran, H., Nair, S., Kaufmann, S., Hillman, K. M., Moradi Marjaneh, M., Beesley, J., & Edwards, S. L. (2024). GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011490
Vancouver
Rivera IS, French JD, Bitar M, Sivakumaran H, Nair S, Kaufmann S, et al. GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011490
BibTeX
@article{Rivera2024,
author = {Rivera, Isela Sarahi and French, Juliet D and Bitar, Mainá and Sivakumaran, Haran and Nair, Sneha and Kaufmann, Susanne and Hillman, Kristine M and Moradi Marjaneh, Mahdi and Beesley, Jonathan and Edwards, Stacey L},
title = {GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011490}
}
EUVIMED